NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
1-Year Est. Return 12.08%
This Quarter Est. Return
1 Year Est. Return
+12.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
+$102M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$21.8M
2
+$19.5M
3
+$15.6M
4
VALN
Valneva
VALN
+$13.5M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.34M

Top Sells

1
+$22.4M
2
+$13.7M
3
+$7.34M
4
INSM icon
Insmed
INSM
+$4.5M
5
LXEO icon
Lexeo Therapeutics
LXEO
+$3.9M

Sector Composition

1 Healthcare 48.34%
2 Technology 15.92%
3 Financials 10.18%
4 Consumer Discretionary 2.98%
5 Industrials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNZA icon
26
LanzaTech
LNZA
$62.1M
$4.29M 0.3%
158,148
MQ icon
27
Marqeta
MQ
$2.09B
$2.57M 0.18%
441,558
ABCL icon
28
AbCellera Biologics
ABCL
$1.63B
$2.24M 0.16%
652,529
-474,386
GLTO icon
29
Galecto
GLTO
$11.3M
$341K 0.02%
99,913
VERV
30
DELISTED
Verve Therapeutics
VERV
– –
-3,000,000
KYTX icon
31
Kyverna Therapeutics
KYTX
$288M
– –
-1,850,000
FOLD icon
32
Amicus Therapeutics
FOLD
$2.61B
– –
-2,750,000
LXEO icon
33
Lexeo Therapeutics
LXEO
$643M
– –
-1,122,581
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$429M
– –
-1,100,000
1
2